Millipore Sigma Vibrant Logo

530487 StemSelect® PD 0332991 - CAS 827022-32-2 - Calbiochem

Übersicht

Replacement Information

Key Spec Table

CAS #Empirical Formula
827022-32-2C₂₄H₂₉N₇O₂ • HCl

Preis & Verfügbarkeit

Bestellnummer VerfügbarkeitVerpackung St./Pkg. Preis Menge
5.30487.0001
Verfügbarkeit wird abgerufen...
Eingeschränkte Verfügbarkeit
Eingeschränkte Verfügbarkeit
Lieferbar 
Produkt wurde eingestellt
Begrenzter Lagerbestand
Bestätigung der Verfügbarkeit erforderlich
    Restmenge: Angebot folgt
      Restmenge: Angebot folgt
      Bitte erfragen
      Kontakt zum Kundenservice
      Contact Customer Service

      Glasflasche 5 mg
      Preis wird abgerufen...
      Preis nicht abrufbar
      Die Mindestmenge muss ein Vielfaches sein von
      Maximum Quantity is
      Bei Bestätigung Weitere Informationen
      Sie haben () gespart
       
      Bitte erfragen
      Description
      OverviewA cell-permeable, orally available and brain permeant, non-toxic pyridopyrimidinone compound that acts as a potent, selective, reversible, ATP competitive inhibitor of Cdk4 and Cdk6 (IC50 = 11, 9, and 15 nM for Cdk4/D1, Cdk4/D3 and Cdk6/D2, respectively). Hence, it reduces retinoblastoma protein phosphorylation at Ser780/Ser795 (IC50 = 66 nM in MDA-435 cells) and arrests cell cycle at G1 phase. Acts as a cytostatic agent, but does induce apoptotic cell death when used alone. However, it potentiates the cytotoxicity of dexamethasone (Cat. No. 265005), bortezomib (Cat. No. 504314), and tamoxifen (Cat. No. 579000) in estrogen receptor (ER)-positive cell lines. Exhibits only a trivial inhibitory activity towards Cdk2/E2, Cdk2/A, Cdk1/B and Cdk5/p25 in a 36-kinase panel (IC50 > 10 µM). Improves endoderm differentiation of late G1-human embryonic stem cells expressing Smad2 or Smad3 (~ 750 nM) and further enhances endoderm differentiation into hepatic and pancreatic progenitor cells. Shown to regress the growth of human breast tumor xenografts in murine models (~150 mg/kg, p.o., daily).

      Please note that the molecular weight for this compound is batch-specific due to variable water content.
      Catalogue Number530487
      Brand Family Calbiochem®
      Synonyms6-Acetyl-8-cyclopentyl-5-methyl-2-(5-(piperazin-1-yl)pyridin-2-ylamino)pyrido[2,3-d]pyrimidin-7(8H)-one, HCl, Cdk4/Cdk6 Inhibitor V, PD-0332991, HCl, PF-332991, HCl
      References
      ReferencesPauklin, S. and Vallier, L., 2013. Cell 155, 135.
      Finn, R.S., et al. 2009. Breast Cancer Res. 11, R17.
      Menu, E., et al. 2008. Cancer Res. 68, 5519.
      Baughn, L.B., et al. 2006. Cancer Res. 66, 7661.
      Fry, D.W., et al. 2004. Mol. Cancer Ther. 3, 1427.
      Product Information
      CAS number827022-32-2
      FormYellow liquid
      Hill FormulaC₂₄H₂₉N₇O₂ • HCl
      Chemical formulaC₂₄H₂₉N₇O₂ • HCl
      ReversibleY
      Quality LevelMQ100
      Applications
      Biological Information
      Primary TargetCdk4 & Cdk6
      Purity≥97% by HPLC
      Physicochemical Information
      Cell permeableY
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Dry Ice Only
      Toxicity Standard Handling
      Storage ≤ -70°C
      Protect from Light Protect from light
      Avoid freeze/thaw Avoid freeze/thaw
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.
      Packaging Information
      Packaged under inert gas Packaged under inert gas
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Bestellnummer GTIN
      5.30487.0001 04055977260823

      Documentation

      StemSelect® PD 0332991 - CAS 827022-32-2 - Calbiochem SDB

      Titel

      Sicherheitsdatenblatt (SDB) 

      Literatur

      Übersicht
      Pauklin, S. and Vallier, L., 2013. Cell 155, 135.
      Finn, R.S., et al. 2009. Breast Cancer Res. 11, R17.
      Menu, E., et al. 2008. Cancer Res. 68, 5519.
      Baughn, L.B., et al. 2006. Cancer Res. 66, 7661.
      Fry, D.W., et al. 2004. Mol. Cancer Ther. 3, 1427.
      Datenblatt

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision02-May-2014 JSW
      Synonyms6-Acetyl-8-cyclopentyl-5-methyl-2-(5-(piperazin-1-yl)pyridin-2-ylamino)pyrido[2,3-d]pyrimidin-7(8H)-one, HCl, Cdk4/Cdk6 Inhibitor V, PD-0332991, HCl, PF-332991, HCl
      DescriptionA cell-permeable, orally available and brain permeant, non-toxic pyridopyrimidinone compound that acts as a potent, selective, reversible, ATP competitive inhibitor of Cdk4 and Cdk6 (IC50 = 11, 9, and 15 nM for Cdk4/D1, Cdk4/D3 and Cdk6/D2, respectively). Hence, it reduces retinoblastoma protein phosphorylation at Ser780/Ser795 (IC50 = 66 nM in MDA-435 cells) and arrests cell cycle at G1 phase. Acts as a cytostatic agent, but does induce apoptotic cell death when used alone. However, it potentiates the cytotoxicity of dexamethasone (Cat. No. 265005), bortezomib (Cat. No. 504314), and tamoxifen (Cat. No. 579000) in estrogen receptor (ER)-positive cell lines. Exhibits only a trivial inhibitory activity towards Cdk2/E2, Cdk2/A, Cdk1/B and Cdk5/p25 in a 36-kinase panel (IC50 > 10 µM). Improves endoderm differentiation of late G1-human embryonic stem cells expressing Smad2 or Smad3 (~ 750 nM) and further enhances endoderm differentiation into hepatic and pancreatic progenitor cells. Shown to regress the growth of human breast tumor xenografts in murine models (~150 mg/kg, p.o., daily).
      FormYellow liquid
      Intert gas (Yes/No) Packaged under inert gas
      CAS number827022-32-2
      Chemical formulaC₂₄H₂₉N₇O₂ • HCl
      Purity≥97% by HPLC
      SolubilityH₂O (10 mg/ml)
      Storage Protect from light
      Avoid freeze/thaw
      ≤ -70°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 6 months at -20°C.
      Toxicity Standard Handling
      ReferencesPauklin, S. and Vallier, L., 2013. Cell 155, 135.
      Finn, R.S., et al. 2009. Breast Cancer Res. 11, R17.
      Menu, E., et al. 2008. Cancer Res. 68, 5519.
      Baughn, L.B., et al. 2006. Cancer Res. 66, 7661.
      Fry, D.W., et al. 2004. Mol. Cancer Ther. 3, 1427.